An article by Sandvik et al outlines the remarkable advances in epilepsy surgery and the impressive range of treatments that have become available as a result. The progress illustrates the need for renewed efforts in Swedish health care to identify patients that could benefit from epilepsy surgery. Physician delay in referring patients with pharmacoresistant epilepsy, capacity for advanced evaluations, and geographical inequality in access to care are some obstacles, that can be mitigated by the recent national guidelines from the National Board of Health and Welfare.